Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels

American Journal of Pathology

Volumn 149, Issue 1, 1996, Pages 259-272

  Weintraub, Andrea S ^a   Giachelli, Cecilia M ^b   Krauss, Robert S ^a   Almeida, Manuela ^b   Taubman, Mark B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; COLLAGEN GEL; OSTEOPONTIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; EXPRESSION VECTOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VIRUS RECOMBINANT;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); AORTA, THORACIC; CELL ADHESION; CELL DIVISION; CLONE CELLS; COLLAGEN; MALE; MUSCLE, SMOOTH, VASCULAR; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIALOGLYCOPROTEINS;

EID: 0029957772     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Ross R: Atherosclerosis: a problem of the biology of arterial walls and their interaction with blood components. Atherosclerosis 1981, 1:293-311
2. Clowes AW, Clowes MM, Fingerle J, Reidy MA: Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharmacol 1989, 14(suppl 6):S12-S15
3. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R: Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253:1129-1132
4. Schwartz SM, Heimark RL, Majesky MW: Developmental mechanisms underlying pathology of arteries. Physiol Rev 1990, 70:1177-1209
5. Califf RM, Fortin DF, Frid DJ, Harlan WR III, Ohman EM, Bengston ER, Nelson CL, Tcheng JE, Mark DB, Stack RS: Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 1991, 17:2B-13B
6. Garratt KN, Edwards WD, Kaufmann UP, Vleistra RE, Holmes DR: Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein grafts: analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol 1991, 17:442-448
7. Isner JM, Pickering JG, Weir L, Jekanowski J, Kearney MA: Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993, 91: 1469-1480
8. Strauss BH, Chisholm RJ, Keeley FW, Gotliev AI, Logan RA, Armstrong PW: Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994, 75:650-658
9. Delvos U, Gajdusek C, Sage H, Harker LA, Schwartz SM: Interactions of vascular wall cells with collagen gels. Lab Invest 1982, 46:61-72
10. Wren FE, Schor AM, Schor SL, Grant ME: Modulation of smooth muscle cell behavior by platelet-derived factors and the extracellular matrix. J Cell Physiol 1986, 127:297-302
11. Boudreau N, Turley E, Rabinovitch M: Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev Biol 1991, 143:235-247
12. Madri JA, Bell L, Marx M, Merwin JR, Basson C, Printz C: Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: models of de-endothelialization and repair. J Cell Biochem 1991, 45:123-130
13. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA: Production of transforming growth factor β-1 during repair of arterial injury. J Clin Invest 1991, 88: 904-910
14. Snow AD, Bolender RP, Wight TN, Clowes AW: Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol 1990, 137:313-330
15. Madri JA, Marx M: Matrix composition, organization, and soluble factors: modulators of microvascular cell differentiation in vitro. Kidney Int 1992, 41:560-565
16. Hinek A, Rabinovitch M: 67-kD elastin-binding protein is a protective "companion" of extracellular insoluble elastin and intracellular tropoelastin. J Cell Biol 1994, 126:563-574
17. Majesky MW: Neointima formation after acute vascular injury: role of counteradhesive extracellular matrix proteins. Texas Heart Inst J 1994, 21:78-85
18. Hedin U, Holm J, Hansson GK: Induction of tenascin in rat arterial injury: relationship to altered smooth muscle cell phenotype. Am J Pathol 1991, 139:649-656
19. Raugi GJ, Mullen JS, Bark DH, Okada T, Mayberg MR: Thrombospondin deposition in rat carotid artery injury. Am J Pathol 1990, 137:179-185
20. RayChaudhury A, Frazier WA, D'Amore PA: Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-β. J Cell Sci 1994, 107: 39-46
21. Ramirez R, Pereira L, Zhang H, Lee B: The fibrillin-Marfan syndrome connection. Bioessays 1993, 15:1-6
22. Yanagi H, Sasaguri Y, Sugama K, Morimatsu M, Nagase H: Production of tissue collagenase (matrix metalloproteinase I) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis 1991, 91:207-216
23. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P: Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994, 75:181-189
24. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, Gluzband YA, Smith L, Weinstein C, Lakatta EG, Crow MT: Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 1994, 75: 41-54
25. Pierschbacher MD, Ruoslahti E: Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309:30-33
26. Oldberg A, Franzen A, Heinegard A: Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an ARG-GLY-ASP binding sequence. Proc Natl Acad Sci USA 1986, 83:8819-8823
27. Paniccia R, Colucci S, Grano M, Serra M, Vallone AZ, Teti A: Immediate cell signal by bone related peptides in human osteoclast-like cells. Am J Physiol 1993, 265: C1289-C1297
28. Nomura S, Wills AJ, Edwards DR, Heath JK, Hogan BLM: Developmental expression of 2AR(osteopontin) and SPARC(osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 1988, 106:441-450
29. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Schwartz S, Johnson RJ: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994, 45:515-524
30. Young MF, Kerr JM, Termine JD, Wewer UM, Wang MG, McBride OW, Fisher LW: cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 1990, 7:491-502
31. Waterhouse P, Parker RS, Guo X, Lala PK, Denhardt DT: Regulated temporal and spatial expression of the calcium-binding proteins calcyclin and OPN (osteopontin) in mouse tissues during pregnancy. Mol Reprod Dev 1992, 32(4):315-323
32. Denhardt DT, Guo X: Osteopontin: a protein with diverse functions. FASEB J 1993, 7:1475-1482
33. Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT: Osteopontin inhibits induction of nitric oxide synthase activity by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 1994, 269:711-715
34. Senger DR, Perruzzi CA, Gracey CF, Papadopoulos A, Tenen DG: Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 1988, 48:5770-5774
35. Senger DR, Perruzzi CA, Papadopoulos A: Elevated expression of secreted phosphoprotein I (osteopontin: 2AR) as a consequence of neoplastic transformation. Anticancer Res 1989, 9:1291-1300
36. Gardner HAR, Berse B, Senger DR: Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene 1994, 9:2321-2326
37. Giachelli CM, Bae N, Lombardi D, Majesky M, Schwartz S: Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I:2AR). Biochem Biophys Res Commun 1991, 177:867-873
38. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993, 92:1686-1696
39. Gadeau AP, Campan M, Millet D, Candresse T, Desgranges C: Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb 1992, 13:120-125
40. Wax SD, Rosenfield CL, Taubman MB: Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J Biol Chem 1994, 269:13041-13047
41. Green RS, Lieb MB, Weintraub AS, Gacheru SN, Rosenfield CL, Shah S, Kagan HM, Taubman MB: Identification of lysyl oxidase and other PDGF-inducible genes in vascular smooth muscle cells by differential screening. Lab Invest 1995, 73:476-482
42. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994, 74:214-224
43. Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichtberger S, Nemerson Y: Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells: role of calcium mobilization and protein kinase C activation. J Clin Invest 1993, 91:547-552
44. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB: The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 1998, 6:2095-2104
45. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
46. Brand SJ, Stone D: Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria. J Clin Invest 1988, 82(3):1059-1066
47. Irving JA, Lala PK: Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-β, IGF-II, and IGFBP-1. Exp Cell Res 1995, 217:419-427
48. Mann R, Mulligan RC, Baltimore D: Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983, 33:153-159
49. Bernanke DH, Markwald RR: Effects of two glycosaminoglycans on seeding of cardiac tissue cells into a collagen-lattice culture system. Anat Rec 1984, 210: 25-31
50. Turley EA, Erickson CA, Tucker R: The retention and ultrastructural appearances of various extracellular matrix molecules incorporated into three-dimensional hydrated collagen lattices. Dev Biol 1985, 109:347-369
51. Chambers AF, Hota C, Prince CW: Adhesion of metastatic ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin. Cancer Res 1993, 53:701-706
52. Butler WT: The nature and significance of osteopontin. Connective Tissue Res 1989, 23:123-136
53. Kleinman HK, McGoodwin EB, Martin GR, Klebe RJ: Localization of the binding site for cell attachment in the α1 (1) chain of collagen. J Biol Chem 1978, 256: 5642-5646
54. Meredith JE, Fazeli B, Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 1993, 4:953-961